Spectrum Pharmaceuticals Acquires Talon Therapeutics
July 17, 2013 07:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., July 17, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCQB:TLON) today announced that a subsidiary of Spectrum Pharmaceuticals, Inc. (Nasdaq:SPPI) entered into an...
Talon Therapeutics, Inc. Reports First Quarter 2013 Financial Results
May 15, 2013 17:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 15, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCQB:TLON), today reported financial results for the three months ended March 31, 2013.
Corporate...
Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2012 Financial Results
April 01, 2013 09:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., April 1, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCQB:TLON), today reported financial results for the fourth quarter and year ended December 31, 2012.
2012...
Talon Therapeutics to Host a Conference Call to Report 2012 Financial Results and Business Update on April 1, 2013
March 19, 2013 09:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 19, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCQB:TLON) will host a conference call on Monday, April 1, 2013 at 9:00AM PDT, to discuss 2012 financial...
Talon Therapeutics Announces Review of Strategic Alternatives
January 07, 2013 09:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 7, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics (OTCBB:TLON), a biopharmaceutical company focused on expert and efficient clinical development of product candidates...
Talon Therapeutics Appoints Elizabeth Weatherman to Board of Directors
January 04, 2013 09:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 4, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics (OTCBB:TLON), a biopharmaceutical company focused on expert and efficient clinical development of product candidates...
Marqibo(R) Data to be Presented in Three Scientific Sessions and at a Product Theater During the American Society of Hematology Annual Meeting
December 05, 2012 09:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON), an oncology and oncology supportive care focused biopharmaceutical company, today announced that...
Talon Therapeutics Announces Publication of the Marqibo(R) (vinCRIStine sulfate LIPOSOME injection) RALLY Study in the Journal of Clinical Oncology (JCO)
November 27, 2012 09:00 ET
|
Talon Therapeutics, Inc.
Data supported FDA accelerated approval of Marqibo (http://jco.ascopubs.org/)
Data published online ahead of print as a Rapid Communication
Data represents the per protocol, planned...
Talon Therapeutics, Inc. Reports Third Quarter 2012 Financial Results
November 14, 2012 09:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCBB:TLON), today reported financial results for the three and nine months ended September 30, 2012.
"FDA...
Talon Therapeutics' Recently Approved Marqibo Presented at 2012 Chemotherapy Foundation Symposium
November 13, 2012 12:44 ET
|
Talon Therapeutics, Inc.
"The Role of Vincristine Sulfate Liposome Injection in Hematologic Malignancies Data" presented by Dr. Dan Douer of Memorial Sloan-Kettering on Nov. 7
Marqibo is indicated for the treatment...